Market Place
Sourcing Support
NewcelX advances T1D therapy with Eledon Pharmaceuticals
30 Apr 2026 //
GLOBENEWSWIRE
NewcelX Prices $1.35M Equity Financing at 30% Premium
01 Apr 2026 //
GLOBENEWSWIRE
NewcelX, Eledon Pharma Partner on NCEL-101 for Type 1 Diabetes
09 Mar 2026 //
PR NEWSWIRE
NewcelX Advances CVR via Peer-Reviewed Mazindol IR/SR Data
12 Feb 2026 //
PR NEWSWIRE
NewcelX Appoints Swiss Big Pharma Leader Dr. Julien Boisdron
05 Jan 2026 //
PR NEWSWIRE
NewcelX Broadens IP Reach With DOXA Patent Application In China
11 Dec 2025 //
PR NEWSWIRE
Newcelx Appoints Jeremy Shefner, MD, Phd, Chief Medical Officer
17 Nov 2025 //
PR NEWSWIRE
Newcelx CEO Issues Letter To Shareholders
04 Nov 2025 //
PR NEWSWIRE
Newcelx Updates Business Strategy Post-Merger With NLS Pharma
03 Nov 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.